• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The management of borderline epithelial tumors of the ovary.

作者信息

Burger C. W., Prinssen H. M., Baak J. P. A., Wagenaar N., Kenemans P.

机构信息

Department of Obstetrics and Gynecology, Division of Oncologic Gynecology, University Hospital Dijkzigt, Rotterdam;Department of Obstetrics and Gynecology, Division of Oncologic Gynecology, University Hospital Vrije Universiteit, Amsterdam; and Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, and Medical Center Alkmaar, Alkmaar, The Netherlands.

出版信息

Int J Gynecol Cancer. 2000 May;10(3):181-197. doi: 10.1046/j.1525-1438.2000.010003181.x.

DOI:10.1046/j.1525-1438.2000.010003181.x
PMID:11240673
Abstract

The histopathological diagnosis and treatment of borderline epithelial tumors of the ovary (BTO) still pose problems to both pathologists and gynecologists. BTO is a disease of younger, fertile females and generally has an excellent prognosis. A minority of patients, however, succumb to this disease. A review of the literature is given addressing aspects of epidemiology, histology, treatment and prognosis, resulting in a proposal for the management of serous and mucinous borderline tumors of the ovary.

摘要

相似文献

1
The management of borderline epithelial tumors of the ovary.
Int J Gynecol Cancer. 2000 May;10(3):181-197. doi: 10.1046/j.1525-1438.2000.010003181.x.
2
[Comparison of two groups of patients with serous and mucinous types of borderline ovarian tumors].[两组浆液性和黏液性交界性卵巢肿瘤患者的比较]
Ginekol Pol. 2003 Jan;74(1):24-31.
3
Clinical factors and biomarkers in ovarian tumors development.卵巢肿瘤发生发展中的临床因素和生物标志物
Rom J Morphol Embryol. 2008;49(3):327-38.
4
Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.儿科和青少年人群中的恶性及交界性上皮性卵巢肿瘤。
Maturitas. 2017 Feb;96:45-50. doi: 10.1016/j.maturitas.2016.11.011. Epub 2016 Nov 15.
5
Borderline epithelial tumors of the ovary.卵巢交界性上皮性肿瘤
Mod Pathol. 2005 Feb;18 Suppl 2:S33-50. doi: 10.1038/modpathol.3800307.
6
The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.p53和Ki67在卵巢上皮性交界性肿瘤中的免疫组化表达。与临床病理因素的相关性。
Rom J Morphol Embryol. 2012;53(4):967-73.
7
Nuclear findings of ovarian surface epithelial tumors.
Diagn Cytopathol. 2000 Jan;22(1):27-9. doi: 10.1002/(sici)1097-0339(200001)22:1<27::aid-dc8>3.0.co;2-g.
8
TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.TFF3表达作为卵巢交界性上皮性肿瘤的分层标志物
Pathol Oncol Res. 2018 Apr;24(2):277-282. doi: 10.1007/s12253-017-0240-4. Epub 2017 May 3.
9
Mucinous tumors of the ovary: a review.卵巢黏液性肿瘤:综述
Int J Gynecol Pathol. 2005 Jan;24(1):4-25.
10
Ovarian epithelial tumors of borderline malignancy in Japan.日本的交界性卵巢上皮性肿瘤
Gynecol Oncol. 1990 Jul;38(1):90-8. doi: 10.1016/0090-8258(90)90017-f.

引用本文的文献

1
Endometrioid adenofibroma of ovary - a literature review.卵巢子宫内膜样腺纤维瘤——文献综述
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):39-49. doi: 10.47162/RJME.66.1.03.
2
Usefulness of COL11A1 as a Prognostic Marker of Tumor Infiltration.COL11A1作为肿瘤浸润预后标志物的效用。
Biomedicines. 2023 Sep 8;11(9):2496. doi: 10.3390/biomedicines11092496.
3
Fertility Sparing Surgery and Borderline Ovarian Tumours.保留生育功能手术与卵巢交界性肿瘤
Cancers (Basel). 2022 Mar 14;14(6):1485. doi: 10.3390/cancers14061485.
4
Develop a nomogram to predict overall survival of patients with borderline ovarian tumors.开发一种列线图以预测交界性卵巢肿瘤患者的总生存期。
World J Clin Cases. 2022 Mar 6;10(7):2115-2126. doi: 10.12998/wjcc.v10.i7.2115.
5
The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women.中国绝经前后女性卵巢恶性肿瘤和交界性肿瘤的患病率
Oncotarget. 2017 Aug 22;8(46):80589-80594. doi: 10.18632/oncotarget.20384. eCollection 2017 Oct 6.
6
Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications.浆液性宫外 Müller 上皮癌的发病机制及治疗意义
Transl Cancer Res. 2015 Feb;4(1):3-13. doi: 10.3978/j.issn.2218-676X.2015.01.06.
7
Controversies in borderline ovarian tumors.卵巢交界性肿瘤中的争议
J Gynecol Oncol. 2015 Oct;26(4):343-9. doi: 10.3802/jgo.2015.26.4.343. Epub 2015 Sep 23.
8
Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary.芳香化酶抑制在复发性低恶性潜能卵巢浆液性肿瘤中的作用
BMJ Case Rep. 2014 Jun 12;2014:bcr2014204287. doi: 10.1136/bcr-2014-204287.
9
Diagnosis, treatment, and follow-up of borderline ovarian tumors.交界性卵巢肿瘤的诊断、治疗和随访。
Oncologist. 2012;17(12):1515-33. doi: 10.1634/theoncologist.2012-0139. Epub 2012 Sep 28.
10
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.良性、低恶性潜能及低级别浆液性上皮性卵巢肿瘤的免疫组织化学分析
BMC Cancer. 2008 Nov 26;8:346. doi: 10.1186/1471-2407-8-346.